L’outil de licence Creative Commons du formulaire de soumission ne fonctionne pas actuellement. Pour ajouter une licence CC à votre thèse ou publication, contactez ruor@uottawa.ca après le dépôt. -- The Creative Commons licence tool in the submission form is currently unavailable. To apply a CC licence to your thesis or publication, contact ruor@uottawa.ca after the deposit.

Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme

En cours de chargement...
Vignette d'image

Nom de la revue

ISSN de la revue

Titre du volume

Éditeur

Université d'Ottawa / University of Ottawa

Résumé

Glioblastoma multiforme is the most common and malignant form of brain cancer in humans. The current prognosis for glioblastoma patients undergoing standard treatment is extremely low, with a median patient survival of 1 to 2 years. Oncolytic viruses are currently being evaluated as promising novel therapies for the treatment of glioblastoma. Our laboratory’s preliminary data has demonstrated that the oncolytic rhabdovirus Farmington effectively eliminates brain tumours, but is also neurosafe. However, the biological mechanisms underlying Farmington’s neurosafety and oncotropism were unknown. Through studying Farmington infection in normal brain cells and brain cancer cells in vitro, we determined that Farmington’s distinct tropism is dependent on the Farmington glycoprotein and the type 1 interferon response.

Description

Mots-clés

Oncolytic virus, Glioblastoma, Virology, Viral glycoprotein, Neurosafety, Interferon, Oncotropism, Rhabdovirus

Citation

Approbation

Évaluation

Complété par

Référencé par